N6 -Methyladenine DNA Modification in the Human Genome

Molecular Cell
Chuan-Le XiaoGuang-Rong Yan

Abstract

DNA N6-methyladenine (6mA) modification is the most prevalent DNA modification in prokaryotes, but whether it exists in human cells and whether it plays a role in human diseases remain enigmatic. Here, we showed that 6mA is extensively present in the human genome, and we cataloged 881,240 6mA sites accounting for ∼0.051% of the total adenines. [G/C]AGG[C/T] was the most significantly associated motif with 6mA modification. 6mA sites were enriched in the coding regions and mark actively transcribed genes in human cells. DNA 6mA and N6-demethyladenine modification in the human genome were mediated by methyltransferase N6AMT1 and demethylase ALKBH1, respectively. The abundance of 6mA was significantly lower in cancers, accompanied by decreased N6AMT1 and increased ALKBH1 levels, and downregulation of 6mA modification levels promoted tumorigenesis. Collectively, our results demonstrate that DNA 6mA modification is extensively present in human cells and the decrease of genomic DNA 6mA promotes human tumorigenesis.

Citations

Sep 29, 2018·Science·Chongyuan LuoJoseph R Ecker
Nov 20, 2018·Expert Review of Neurotherapeutics·Antonio L TeixeiraSudhakar Selvaraj
May 31, 2019·Cellular and Molecular Life Sciences : CMLS·Myles H Alderman, Andrew Z Xiao
Jul 13, 2019·Bioinformatics·Cong PianXiaodan Fan
Jul 25, 2019·Environmental and Molecular Mutagenesis·Nidhi SharmaAishwarya Prakash
Sep 12, 2019·EvoDevo·Shuonan HeChristine E Schnitzler
Sep 21, 2019·Human Genetics·Mohit K MidhaKuo-Ping Chiu
Nov 14, 2019·Current Pharmaceutical Design·Francesco GuarasciGiuseppe Passarino
Jan 10, 2020·Plant Biotechnology Journal·Pingxian ZhangXiaofeng Gu
Feb 14, 2020·Cell Research·Min ZhangHaitao Li
Mar 24, 2020·Nature Chemical Biology·Michael U MusheevChristof Niehrs
Nov 16, 2019·Nature Reviews. Microbiology·María A Sánchez-Romero, Josep Casadesús
May 19, 2020·Epigenetics : Official Journal of the DNA Methylation Society·Joy N IsmailMargret Shirinian
May 20, 2020·Scientific Reports·Zhenxi ZhangQuan Du
May 26, 2020·Critical Reviews in Biochemistry and Molecular Biology·Huidong Zhang
Apr 14, 2020·Aging·Ye GuoDonghong Zhang
Aug 19, 2020·Essays in Biochemistry·Anusha SriramanKyle M Miller
May 16, 2020·Annual Review of Genomics and Human Genetics·Alexej Abyzov, Flora M Vaccarino
Aug 14, 2020·Chembiochem : a European Journal of Chemical Biology·Jenna N BeyerGeorge M Burslem
Sep 15, 2019·Journal of Cell Science·Lotte VanheerVincent Pasque
Oct 28, 2019·Essays in Biochemistry·Natasha Jansz
Mar 25, 2020·Science Advances·Karolos DouvlataniotisColm E Nestor
Feb 11, 2020·Frontiers in Genetics·Jingwen ZengTatsuya Akutsu
Apr 29, 2020·Nature Chemical Biology·Ye WangGuifang Jia
Dec 19, 2018·Nature Cell Biology·Sarah-Lena OffenburgerBen Lehner
May 8, 2019·Nature Structural & Molecular Biology·Eric MetzgerRoland Schüle
Jun 19, 2019·International Journal of Molecular Sciences·Zhiqing LiQingyou Xia
Jul 28, 2019·Human Molecular Genetics·Matthew J ArmstrongPeng Jin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.